Aung Naing, MD
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aung Naing, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07500298 · Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal CancerM.D. Anderson Cancer Center · recruiting · Phase 1, SAR445877, FOlfox6 · principal investigator
- Ph1NCT06990698 · A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid TumorsZhuhai Fapon Biopharma Co., Ltd. · recruiting · Advanced Solid Tumors · principal investigator
- Ph2NCT06651593 · Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid TumorsM.D. Anderson Cancer Center · recruiting · Solid Tumors · principal investigator
- Ph2NCT06567314 · Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell CarcinomaM.D. Anderson Cancer Center · recruiting · Cutaneous Squamous Cell Carcinoma · principal investigator
- Ph1NCT06563375 · Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid TumorsM.D. Anderson Cancer Center · recruiting · Solid Tumor · principal investigator
- Ph1NCT06163391 · A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic CancerSOTIO Biotech AG · active not recruiting · Advanced Solid Tumor, Metastatic Solid Tumor · principal investigator
- Ph1/Ph2NCT05672459 · A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid TumorsM.D. Anderson Cancer Center · active not recruiting · Solid Tumor · principal investigator
- Ph2NCT04171219 · Talabostat and Pembrolizumab for the Treatment of Advanced Solid CancersM.D. Anderson Cancer Center · terminated · Advanced Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm · principal investigator
- Ph1NCT03852511 · First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody)Akamis Bio · completed · Metastatic Cancer, Epithelial Tumor · principal investigator
- Ph1NCT02419495 · Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer Center · terminated · Advanced Malignant Solid Neoplasm, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 · principal investigator
- Ph3NCT01952847 · Randomized Trial of Glutamine in Patients With Mucositis or EsophagitisM.D. Anderson Cancer Center · terminated · Advanced Cancers · principal investigator
- Ph1NCT01529593 · Temsirolimus in Combination With Metformin in Patients With Advanced CancersM.D. Anderson Cancer Center · terminated · Advanced Cancers · principal investigator
- N/ANCT01462383 · The Role of the EKG in Anticancer Drug DevelopmentM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT01432119 · Phase 1 Trial With SIR-Spheres and Cetuximab +/- ErlotinibM.D. Anderson Cancer Center · withdrawn · Advanced Cancers · principal investigator
- N/ANCT00949390 · Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical TrialsM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT00752011 · Phase I Study of TAS-106 in Combo With CarboplatinM.D. Anderson Cancer Center · completed · Cancer, Solid Tumors · principal investigator
- Ph1NCT00629200 · Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesM.D. Anderson Cancer Center · completed · Advanced Cancer, Solid Tumors · principal investigator
- Ph1NCT00495872 · Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid TumorM.D. Anderson Cancer Center · completed · Solid Tumors · principal investigator
- Ph1NCT00489593 · Olanzapine in Patients With Advanced Cancer and Weight LossM.D. Anderson Cancer Center · completed · Advanced Cancer, Weight Loss · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.